Abstract
In this thesis we aim to optimize existing immunotherapy for hepatocellular carcinoma (HCC) with a strong emphasis on checkpoint inhibition. We aim to detect tumor-associated mutations in paired circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) in a western cohort of HCC patients.
Original language | English |
---|---|
Awarding Institution |
|
Supervisors/Advisors |
|
Award date | 1 Jun 2021 |
Place of Publication | Rotterdam |
Print ISBNs | 978-94-6416-629-3 |
Publication status | Published - 1 Jun 2021 |
Bibliographical note
The research was funded by:- China Scholarship Council
- Nederlandse Vereniging Voor Gastro-enterologie